Press Release
Category Added in a WPeMatico Campaign
-
Business Wire19 March 2026
TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
Primary endpoint met in Phase 3 TALAPRO-3 study demonstrating a statistically significant and clinically meaningful reduction in risk of disease…
Read More » -
Business Wire19 March 2026
Infobip’s 20-Year Analysis of 3.8 Trillion Messages Reveals Rise of Omnichannel, RCS and AI-Driven Communication
Analysis of 628 billion interactions in 2025 highlights the shift to conversational experiences, with nearly 98% of traffic now sent…
Read More » -
Business Wire19 March 2026
Caleres Reports Fourth Quarter & Fiscal 2025 Results
Fourth quarter adjusted EPS exceeds guidance. Lead Brands, eCommerce and International drive growth. Caleres completes Stuart Weitzman integration. ST. LOUIS–(BUSINESS…
Read More » -
Business Wire19 March 2026
Accenture Reports Second-Quarter Fiscal 2026 Results
Accenture delivers record new bookings, revenues at the top of the company’s guided range, strong profitability and robust free cash…
Read More » -
Business Wire19 March 2026
EOSE Investor Reminder: Eos Energy Faces Securities Fraud Class Action after Stock Drops 39% – Contact BFA Law by May 5 Legal Deadline
Eos Energy faces securities fraud allegations for misrepresenting near-term revenue growth and the timing, execution, and feasibility of its manufacturing…
Read More » -
Cision PR Newswire19 March 2026Lumito and Tethis complete proof-of-concept study demonstrating compatibility between Lumito’s UCNP imaging and Tethis’ SmartBioSurface® slides
LUND, Sweden and MILAN, March 19, 2026 /PRNewswire/ — Lumito AB (“Lumito”) and Tethis S.p.A. (“Tethis”) today announce the completion…
Read More » -
Cision PR Newswire19 March 2026Cardinal Infrastructure Group Inc. Announces Full Year 2025 Results and Affirms 2026 Guidance
RALEIGH, N.C., March 19, 2026 /PRNewswire/ — Cardinal Infrastructure Group Inc. (NASDAQ: CDNL) (“Cardinal” or the “Company”), today announced full…
Read More » -
Cision PR Newswire19 March 2026DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Fourth quarter 2025 revenues grew sequentially to $5.2 million as compared to $5.0 million in the third quarter of 2025…
Read More » -
Cision PR Newswire19 March 2026
Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China’s first hemophilia B gene therapy, was officially approved in Macao, China
SHANGHAI, March 19, 2026 /PRNewswire/ — Belief BioMed (“BBM”) today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been…
Read More » -
Cision PR Newswire19 March 2026Viettel Ranks No.1 Globally in Telecom Brand Strength
HANOI, Vietnam, March 19, 2026 /PRNewswire/ — Viettel Group has been ranked as the world’s strongest telecom brand, achieving a…
Read More »